The DOI matches its Crossref record; 339 of the 339 references it cites were found in a registry or an index.
The Role of NMDA Receptors in Alzheimer’s Disease
Open accessAbstract
In Alzheimer's disease (AD), early synaptic dysfunction is associated with the increased oligomeric amyloid-beta peptide, which causes NMDAR-dependent synaptic depression and spine elimination. Memantine, low-affinity NMDAR channel blocker, has been used in the treatment of moderate to severe AD. However, clear evidence is still deficient in demonstrating the underlying mechanisms and a relationship between NMDARs dysfunction and AD. This review focuses on not only changes in expression of different NMDAR subunits, but also some unconventional modes of NMDAR action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“N-methyl-d-aspartate receptor (NMDAR) activation and related excitotoxic events that lead to synaptic dysfunction has also been associated with AD pathology (Liu et al. 2019).”
From Alzheimer’s disease: Targeting the glutamatergic system (2020) · cites this paper as Liu et al. 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–339 of 339
Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
Wenk, G. L. (2006) · PubMed · Cited by 134
Amyloid-β Induces Caspase-Dependent Loss of PSD-95 and Synaptophysin Through NMDA Receptors
Liu, J., Chang, L., Roselli, F., Almeida, O. F. X., Gao, X., Wang, X., Yew, D. T. W., & Wu, Y. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100948 · Cited by 133
Self-citationPresynaptic NR2A-containing NMDA receptors implement a high-pass filter synaptic plasticity rule
Bidoret, C., Ayon, A., Barbour, B., & Casado, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904284106 · Cited by 133
Expression of A152T human tau causes age‐dependent neuronal dysfunction and loss in transgenic mice
Maeda, S., Djukic, B., Taneja, P., Yu, G.-Q., Lo, I., Davis, A., Craft, R., Guo, W., Wang, X., Kim, D., et al. (2016) · EMBO Reports · doi:10.15252/embr.201541438 · Cited by 133
New developments on the role of NMDA receptors in Alzheimer's disease
Malinow, R. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.09.001 · Cited by 132
Roles of Presynaptic NMDA Receptors in Neurotransmission and Plasticity
Banerjee, A., Larsen, R. S., Philpot, B. D., & Paulsen, O. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.11.001 · Cited by 131
Decker, J. M., Krüger, L., Sydow, A., Dennissen, F. J. A., Šišková, Z., Mandelkow�, E., & Mandelkow, E. (2016) · EMBO Reports · doi:10.15252/embr.201541439 · Cited by 130
Delacourte, A., Flament, S., Dibe, E. M., Hublau, P., Sablnni�re, P., H�mon, B., Sh�rrer, V., & D�fossez, A. (1990) · Acta Neuropathologica · doi:10.1007/bf00308912 · Cited by 129
Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease
Camandola, S., & Mattson, M. P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.10.005 · Cited by 128
Distinct pharmacological and functional properties of NMDA receptors in mouse cortical astrocytes
Palygin, O., Lalo, U., & Pankratov, Y. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01374.x · Cited by 127
Dunah, A. W., Luo, J., Wang, Y., Yasuda, R. P., & Wolfe, B. B. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.429 · Cited by 127
Vizi, E. S., Kisfali, M., & Lőrincz, T. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.10.005 · Cited by 125
Fonseca, A. C., Ferreiro, E., Oliveira, C., Cardoso, S., & Pereira, C. (2013) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2013.08.007 · Cited by 122
On the Hypes and Falls in Neuroprotection: Targeting the NMDA Receptor
Villmann, C., & Becker, C. (2007) · The Neuroscientist · doi:10.1177/1073858406296259 · Cited by 121
Characterization of a Soluble Ligand Binding Domain of the NMDA Receptor Regulatory Subunit NR3A
Yao, Y., & Mayer, M. L. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0560-06.2006 · Cited by 120
Low, C., & Wee, K. S.-L. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064006 · Cited by 120
Differential expression of N‐methyl‐d‐aspartate receptor NR2 isoforms in Alzheimer's disease
Hynd, M., Scott, H., & Dodd, P. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02548.x · Cited by 118
Neuroprotection by the NR3A Subunit of the NMDA Receptor
Nakanishi, N., Tu, S., Shin, Y., Cui, J., Kurokawa, T., Zhang, D., Chen, H.-S. V., Tong, G., & Lipton, S. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1067-09.2009 · Cited by 118
Yang, J. F., Woodhall, G. L., & Jones, R. S. G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4413-05.2006 · Cited by 117
Costa, R. O., Lacor, P. N., Ferreira, I. L., Resende, R., Auberson, Y. P., Klein, W. L., Oliveira, C. R., Rego, A. C., & Pereira, C. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00848.x · Cited by 116
Perszyk, R. E., DiRaddo, J. O., Strong, K. L., Low, C.-M., Ogden, K. K., Khatri, A., Vargish, G. A., Pelkey, K. A., Tricoire, L., Liotta, D. C., et al. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105130 · Cited by 116
Andersson, O., Stenqvist, A., Attersand, A., & von Euler, G. (2001) · Genomics · doi:10.1006/geno.2001.6666 · Cited by 114
Molecular mechanism of ligand recognition by NR3 subtype glutamate receptors
Yao, Y., Harrison, C. B., Freddolino, P. L., Schulten, K. J., & Mayer, M. L. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.140 · Cited by 112
Bi, H., & Sze, C. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00087-4 · Cited by 111
Developmental loss of miniature N -methyl- d -aspartate receptor currents in NR2A knockout mice
Townsend, M., Yoshii, A., Mishina, M., & Constantine‐Paton, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0335786100 · Cited by 107
Molnár, E., Váradi, A., McIlhinney, R. A. J., & Ashcroft, S. J. H. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00890-l · Cited by 105
Rong, Y., Lü, X., Bernard, A., Khrestchatisky, M., & Baudry, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00565.x · Cited by 102
Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release
Ferreira, I. L., Ferreiro, E. B., Schmidt, J., Cardoso, J. M. R., Pereira, C., Carvalho, A. L., Oliveira, C. R., & Rego, A. C. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.006 · Cited by 102
Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors
Yi, F., Mou, T., Dorsett, K. N., Volkmann, R. A., Menniti, F. S., Sprang, S. R., & Hansen, K. B. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.014 · Cited by 102
Differential Regulation of Evoked and Spontaneous Release by Presynaptic NMDA Receptors
Abrahamsson, T., Chou, C. Y. C., Li, S. S. Y., Mancino, A. S., Costa, R. P., Brock, J. A., Nuro, E., Buchanan, K. A., Elgar, D., Blackman, A. V., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.030 · Cited by 102
Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss
Birnbaum, J. H., Bali, J., Rajendran, L., Nitsch, R. M., & Tackenberg, C. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.160 · Cited by 101
New pharmacologic horizons in the treatment of Parkinson disease
Bonuccelli, U., & Dotto, P. D. (2006) · Neurology · doi:10.1212/wnl.67.7_suppl_2.s30 · Cited by 101
Wee, K. S.-L., Zhang, Y., Khanna, S., & Low, C. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21747 · Cited by 99
Modulation of cellular differentiation by N ‐methyl‐ d ‐aspartate receptors in osteoblasts
Hinoi, E., Fujimori, S., & Yoneda, Y. (2003) · The FASEB Journal · doi:10.1096/fj.02-0820fje · Cited by 99
Whitesell, J. D., Buckley, A. R., Knox, J. E., Kuan, L., Graddis, N., Pelos, A., Mukora, A., Wakeman, W., Bohn, P., Ho, A., et al. (2019) · Journal of Comparative Neurology · doi:10.1002/cne.24555 · Cited by 99
Tau protein is involved in morphological plasticity in hippocampal neurons in response to BDNF
Chen, Q., Zhou, Z., Zhang, L., Wang, Y., Zhang, Y., Zhong, M., Xu, S., Chen, C., Li, L., & Yu, Z. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.12.013 · Cited by 98
Diverse modes of NMDA receptor positive allosteric modulation: Mechanisms and consequences
Hackos, D. H., & Hanson, J. E. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.037 · Cited by 98
Groot, C. J. A. D., Langeveld, C. H., Jongenelen, C. A. M., Montagne, L., van der Valk, P., & Dijkstra, C. D. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970801)49:3 · Cited by 97
Synapse-Specific Control of Experience-Dependent Plasticity by Presynaptic NMDA Receptors
Larsen, R. S., Smith, I. T., Miriyala, J., Han, J. E., Corlew, R., Smith, S. L., & Philpot, B. D. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.039 · Cited by 97
Combination Therapy for Alzheimerʼs Disease
Patel, L., & Grossberg, G. T. (2011) · Drugs & Aging · doi:10.2165/11591860-000000000-00000 · Cited by 95
Presynaptic NMDA receptors: Roles and rules
Bouvier, G., Bidoret, C., Casado, M., & Paoletti, P. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.033 · Cited by 94
Zhang, J., & Diamond, J. S. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21089 · Cited by 94
Murugan, M., Viswanathan, S., Lu, J., Ling, E., & Kaur, C. (2011) · Glia · doi:10.1002/glia.21121 · Cited by 94
Foster, T. C., Kyritsopoulos, C., & Kumar, A. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.012 · Cited by 94
Misra, C., Brickley, S. G., Farrant, M., & Cull-Candy, S. G. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00147.x · Cited by 93
Kodis, E. J., Choi, S. H., Swanson, E., Ferreira, G., & Bloom, G. S. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.05.017 · Cited by 93
A structural biology perspective on NMDA receptor pharmacology and function
Regan, M. C., Hernandez, A. R., & Furukawa, H. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.07.012 · Cited by 92
Bi, X., Gall, C. M., Zhou, J., & Lynch, G. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00132-x · Cited by 92
Haas, L. T., Kostylev, M. A., & Strittmatter, S. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.584342 · Cited by 91
Benarroch, E. E. (2011) · Neurology · doi:10.1212/wnl.0b013e31821b7cc9 · Cited by 90
Usardi, A., Pooler, A. M., Seereeram, A., Reynolds, C. H., Derkinderen, P., Anderton, B. H., Hanger, D. P., Noble, W. J., & Williamson, R. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08218.x · Cited by 89
Controlling NMDA Receptor Subunit Composition Using Ectopic Retention Signals
Stroebel, D., Carvalho, S., Grand, T., Zhu, S., & Paoletti, P. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2736-14.2014 · Cited by 88
Szász, B. K., Mike, Á., Károly, R., Gerevich, Z., Illés, P., Vizi, E. S., & Kiss, J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.014 · Cited by 87
Sinor, J. D., Du, S., Venneti, S., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08831.2000 · Cited by 86
NMDA Receptors in Glial Cells: Pending Questions
Džamba, D., Honsa, P., & Anděrová, M. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030002 · Cited by 85
Extracellular Level of GABA and Glu: In Vivo Microdialysis-HPLC Measurements
Nyitrai, G., Kékesi, K. A., & Juhász, G. D. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777323674 · Cited by 85
Towards resolving the presynaptic NMDA receptor debate
Bouvier, G., Larsen, R. S., Moreno, A. R., Paulsen, O., & Sjöström, P. J. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.12.020 · Cited by 84
Structural Mechanism of Functional Modulation by Gene Splicing in NMDA Receptors
Regan, M. C., Grant, T., McDaniel, M. J., Karakaş, E., Zhang, J., Traynelis, S. F., Grigorieff, N., & Furukawa, H. (2018) · Neuron · doi:10.1016/j.neuron.2018.03.034 · Cited by 84
Doy�re, V., Errington, M. L., Laroche, S., & Bliss, T. V. P. (1996) · Hippocampus · doi:10.1002/(sici)1098-1063(1996)6:1 · Cited by 79
Burzomato, V., Frugier, G., Pérez-Otaño, I., Kittler, J. T., & Attwell, D. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.195503 · Cited by 78
Recruiting Extrasynaptic NMDA Receptors Augments Synaptic Signaling
Harris, A. Z., & Pettit, D. L. (2007) · Journal of Neurophysiology · doi:10.1152/jn.01169.2007 · Cited by 78
Bhattacharya, S., Khatri, A., Swanger, S. A., DiRaddo, J. O., Yi, F., Hansen, K. B., Yuan, H., & Traynelis, S. F. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.010 · Cited by 77
Babiec, W. E., Guglietta, R., Jami, S. A., Morishita, W., Malenka, R. C., & O’Dell, T. J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5419-13.2014 · Cited by 76
NMDA-Receptor Activation but Not Ion Flux Is Required for Amyloid-Beta Induced Synaptic Depression
Tamburri, A., Dudilot, A., Licea, S., Bourgeois, C., & Boehm, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065350 · Cited by 75
Grochowska, K. M., Yuanxiang, P., Bär, J., Raman, R., Brugal, G. N., Sahu, G., Schweizer, M., Bikbaev, A. F., Schilling, S., Demuth, H., et al. (2017) · EMBO Reports · doi:10.15252/embr.201643519 · Cited by 75
Opposing Synaptic Regulation of Amyloid-β Metabolism by NMDA Receptors In Vivo
Verges, D. K., Restivo, J. L., Goebel, W. D., Holtzman, D. M., & Cirrito, J. R. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0607-11.2011 · Cited by 74
Glutamate and Glycine Binding to the NMDA Receptor
Yu, A., & Lau, A. Y. (2018) · Structure · doi:10.1016/j.str.2018.05.004 · Cited by 73
Sun, X., Tuo, Q., Liuyang, Z., Xie, A., Feng, X.-L., Yan, X., Qiu, M., Shen, L., Wang, X.-L., Cao, F.-Y., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.329 · Cited by 71
Caldeira, G. L., Ferreira, I. L., & Rego, A. C. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121444 · Cited by 70
Long-Term Potentiation in the Visual Cortex Requires Both Nitric Oxide Receptor Guanylyl Cyclases
Haghikia, A., Mergia, E., Friebe, A., Eysel, U. T., Koesling, D., & Mittmann, T. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4706-06.2007 · Cited by 70
GlutamateNMDA receptor NR1 subunit mRNA expression in Alzheimer's disease
Hynd, M. R., Scott, H. L., & Dodd, P. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00409.x · Cited by 66 · cited 1×
“Some reported that levels of both GluN1 mRNA (Ułas and Cotman, 1997; Hynd et al., 2001) and GluN1 protein (Sze et al., 2001; Jacob et al., 2007) were significantly lower in AD patients.”
BackgroundPresynaptic NMDA Receptor Mechanisms for Enhancing Spontaneous Neurotransmitter Release
Kunz, P. A., Roberts, A. C., & Philpot, B. D. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2482-12.2013 · Cited by 66
Postsynaptic, not presynaptic NMDA receptors are required for spike-timing-dependent LTD induction
Carter, B. C., & Jahr, C. E. (2016) · Nature Neuroscience · doi:10.1038/nn.4343 · Cited by 66
Müller, T., Albrecht, D., & Gebhardt, C. (2009) · Learning & Memory · doi:10.1101/lm.1398709 · Cited by 65
Kiss, J., Szász, B. K., Fodor, L., Mike, Á., Lenkey, N., Kurkó, D., Nagy, J., & Vizi, E. S. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.12.005 · Cited by 65
Raveendran, R., Devi Suma Priya, S., Mayadevi, M., Steephan, M., Santhoshkumar, T. R., Cheriyan, J., Sanalkumar, R., Pradeep, K. K., James, J., & Omkumar, R. V. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06108.x · Cited by 63
Shi, X., Sun, K., Hu, R., Liu, X.-Y., Hu, Q., Sun, X., Yao, B., Sun, N., Hao, J., Wei, P., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1327-16.2016 · Cited by 63
Recent Progress in the Pharmacotherapy of Alzheimer’s Disease
Khoury, R., Patel, K., Gold, J., Hinds, S., & Grossberg, G. T. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0499-x · Cited by 62
Distribution of N-methyl-d-aspartate receptors (NMDARs) in the developing rat brain
Takai, H., Katayama, K., Uetsuka, K., Nakayama, H., & Doi, K. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(03)00030-3 · Cited by 61
The NR2B Subtype of NMDA Receptor: A Potential Target for the Treatment of Alcohol Dependence
Nagy, J. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043337409 · Cited by 61
Ávila, J., Llorens-Martı́n, M., Pallas‐Bazarra, N., Bolós, M., Perea, J. R., Rodríguez-Matellán, A., & Hernández, F. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00626 · Cited by 61
Domingues, A. M. D. J., Almeida, S., DACRUZESILVA, E., Oliveira, C. R., & Rego, A. C. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.03.001 · Cited by 60
Swanger, S. A., Vance, K. M., Acker, T. M., Zimmerman, S. S., DiRaddo, J. O., Myers, S. J., Bundgaard, C., Mosley, C. A., Summer, S. L., Menaldino, D. S., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00329 · Cited by 60
The regulation of N‐methyl‐ d ‐aspartate receptors by Src kinase
Groveman, B. R., Feng, S., Fang, X., Pflueger, M., Lin, S.-X., Bienkiewicz, E. A., & Yu, X. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08413.x · Cited by 59
Glutamate increases tau phosphorylation in primary neuronal cultures from fetal rat cerebral cortex.
Sindou, P., Lesort, M., Couratier, P., Yardin, C., Esclaire, F., & Hugon, J. (1994) · Brain Research · doi:10.1016/0006-8993(94)90064-7 · Cited by 58
Genetic Deletion of NR3A Accelerates Glutamatergic Synapse Maturation
Henson, M. A., Larsen, R. S., Lawson, S. N., Pérez‐Otaño, I., Nakanishi, N., Lipton, S. A., & Philpot, B. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042327 · Cited by 58
Renal NMDA receptors independently stimulate proximal reabsorption and glomerular filtration
Deng, A., & Thomson, S. C. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90391.2008 · Cited by 56
Structure-based discovery of antagonists for GluN3-containing N-methyl-d-aspartate receptors
Kvist, T., Greenwood, J. R., Hansen, K. B., Traynelis, S. F., & Bräuner‐Osborne, H. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.003 · Cited by 56
Basuroy, S., Leffler, C. W., & Parfenova, H. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00023.2013 · Cited by 55
Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-β
Wang, Z.-C., Zhao, J., & Li, S. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1383-2 · Cited by 54
Sun, W., Hansen, K. B., & Jahr, C. E. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.018 · Cited by 54
Ułas, J., & Cotman, C. W. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00023-7 · Cited by 51
Balderas, P. M. D. O., & Aguilera, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126314 · Cited by 50
Effect of acute NR2B antagonist treatment on long-term potentiation in the rat hippocampus
Graef, J. D., Newberry, K. S., Newton, A. E., Pieschl, R. L., Shields, E. E., Luan, F.-N., Simmermacher, J., Luchetti, D., Schaeffer, E., Li, Y., et al. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.019 · Cited by 47
Pre- and postsynaptic localization of NMDA receptor subunits at hippocampal mossy fibre synapses
Berg, L., Larsson, M., Morland, C., & Gundersen, V. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.061 · Cited by 47
NMDA receptors mediate contractile responses in human airway smooth muscle cells
Anaparti, V., Ilarraza, R., Orihara, K., Stelmack, G. L., Ojo, O. O., Mahood, T. H., Unruh, H. W., Halayko, A. J., & Moqbel, R. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00402.2014 · Cited by 46
Growth of the NMDA receptor industrial complex
Sheng, M., & Lee, S. H. (2000) · Nature Neuroscience · doi:10.1038/76576 · Cited by 45
Memantine and Brain Atrophy in Alzheimer's Disease: A 1-Year Randomized Controlled Trial
Wilkinson, D. G., for the Study 10112 investigators, Fox, N. C., Barkhof, F., Phul, R. K., Lemming, O. M., & Scheltens, P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111616 · Cited by 45
Trafficking and Targeting of NMDA Receptors
Petralia, R. S., Wenthold, R. J., & Al‐Hallaq, R. A. (2008) · Frontiers in neuroscience · doi:10.1201/9781420044157.ch8 · Cited by 45
Mota, S. I., Ferreira, I. L., Pereira, C., Oliveira, C. R., & Rego, A. C. (2012) · Current Alzheimer Research · doi:10.2174/156720512802455322 · Cited by 42
Sindou, P., Couratier, P., Barthe, D., & Hugon, J. (1992) · Brain Research · doi:10.1016/0006-8993(92)90476-p · Cited by 41
Gérard, F., & Hansson, E. (2012) · Brain Research · doi:10.1016/j.brainres.2012.07.032 · Cited by 41
Functional NMDA receptors with atypical properties are expressed in podocytes
Anderson, M., Suh, J. M., Kim, E. Y., et al. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00268.2010 · Cited by 41
Zong, N., Li, F., Deng, Y., Shi, J., Jin, F. J., & Gong, Q. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.055 · Cited by 41
Long-Term Depression Is Independent of GluN2 Subunit Composition
Wong, J. M., & Gray, J. A. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0394-18.2018 · Cited by 39
Analysis of NMDA Receptors in the Human Spinal Cord
Sundström, E., Whittemore, S. R., Mo, L., & Seiger, Å. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6691 · Cited by 37
Non-ionotropic signaling by the NMDA receptor: controversy and opportunity
Gray, J. A., Zito, K., & Hell, J. W. (2016) · F1000Research · doi:10.12688/f1000research.8366.1 · Cited by 37
Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells
Li, Y., Chang, L., Song, Y., Gao, X., Roselli, F., Liu, J., Zhou, W., Fang, Y., Wei, L., Li, H., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160297 · Cited by 37
Self-citationKato, H., Narita, M., Miyatake, M., Yajima, Y., & Suzuki, T. (2005) · Synapse · doi:10.1002/syn.20213 · Cited by 36
Sproul, A. D., Steele, S. L., Thai, T. L., Yu, S.-P., Klein, J. D., Sands, J. M., & Bell, P. D. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00666.2010 · Cited by 35
Rossi, B., Ogden, D., Llano, I., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039983 · Cited by 34
Characterisation of the human NMDA receptor subunit NR3A glycine binding site
Nilsson, A., Duan, J., Mo-Boquist, L.-L., Benedikz, E., & Sundström, E. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.12.002 · Cited by 32
Martínez-Turrillas, R., Puerta, E., Chowdhury, D., Marco, S., Watanabe, M., Aguirre, N., & Pérez‐Otaño, I. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.07.001 · Cited by 31
Therapeutic peptides for CNS indications: Progress and challenges
Morimoto, B. H. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.09.011 · Cited by 31
Franco, R., Aguinaga, D., Reyes‐Resina, I., Canela, E. I., Lillo, J., Tarutani, A., Hasegawa, M., del Ser‐Badia, A., del Rı́o, J. A., Kreutz, M. R., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00273 · Cited by 31
Presynaptic NMDA receptors: Are they dendritic receptors in disguise?
Duguid, I. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.12.004 · Cited by 29
Bendová, Z., Sumová, A., & Mikkelsen, J. D. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.01.016 · Cited by 28
Pharmacotherapeutic strategies in the treatment of severe Alzheimer’s disease
Deardorff, W. J., & Grossberg, G. T. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1215431 · Cited by 28
Effect of the NR3 subunit on ethanol inhibition of recombinant NMDA receptors
Smothers, C. T., & Woodward, J. J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03315-8 · Cited by 27
Chang, L., Zhang, Y., Liu, J., Song, Y., Lv, A., Li, Y., Zhou, W., Yan, Z., Almeida, O. F. X., & Wu, Y. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150942 · Cited by 27
Self-citationChung, C. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0113-y · Cited by 26
Farinelli, M., Heitz, F. D., Grewe, B. F., Tyagarajan, S. K., Helmchen, F., & Mansuy, I. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034047 · Cited by 23
Yux, L. X., Foster, T. P., Sarver, R. W., et al. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950110h · Cited by 23
Endoplasmic reticulum stress promotes amyloid-beta peptides production in RGC-5 cells
Liu, B., Zhu, Y., Zhou, J., Wei, Y., Long, C., Chen, M., Ling, Y. P., Ge, J., & Zhuo, Y. (2014) · Cell Stress and Chaperones · doi:10.1007/s12192-014-0506-7 · Cited by 21
Li, J.-L., Zhao, L., Cui, B., Deng, L., Ning, G., & Liu, J. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.38 · Cited by 21
Self-citationBeyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer’s disease
Ruthirakuhan, M. T., Herrmann, N., Suridjan, I., Abraham, E. H., Farber, I., & Lanctôt, K. L. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1258060 · Cited by 21
Fernandes, A., Wojcik, T., Baireddy, P., Pieschl, R. L., Newton, A. E., Tian, Y., Hong, Y., Bristow, L. J., & Li, Y. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.044 · Cited by 19
Modulating synaptic NMDA receptors
Tovar, K. R., & Westbrook, G. L. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.023 · Cited by 19
Yang, J. F., Chamberlain, S. E. L., Woodhall, G. L., & Jones, R. S. G. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.157974 · Cited by 18
Kong, M., Ba, M., Liu, C., Zhang, Y., Zhang, H., & Qiu, H. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.12.059 · Cited by 18
Mesic, I., Madry, C., Geider, K., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.014 · Cited by 17
Yu, L. X., Foster, T. P., Sarver, R. W., et al. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js9503901 · Cited by 16
Aβ and the dementia syndrome: Simple versus complex perspectives
Hunter, S., Smailagic, N., & Brayne, C. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13025 · Cited by 15
Suga, K., Saito, A., & Akagawa, K. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.01.001 · Cited by 13
Cavara, N. A., Orth, A., Hicking, G., et al. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-133 · Cited by 12
Paterlini, M., Valerio, A., Baruzzi, F., et al. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00087-1 · Cited by 12
Antošová, M., & Strapková, A. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71042-9 · Cited by 10
Separate functional properties of NMDARs regulate distinct aspects of spatial cognitionPreprint
Sanders, E. M., Nyarko-Odoom, A. O., Zhao, K., Nguyen, M., Liao, H. H., Keith, M., Pyon, J., Kozma, A., Sanyal, M., McHail, D. G., et al. (2018) · Learning & Memory · doi:10.1101/lm.047290.118 · Cited by 10
NMDA receptor mobility: cultures versus acute brain slices or neonatal versus mature synapses?
Köhr, G. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.144865 · Cited by 4
Flagged first, then by citations
Cited by
Sorted by citations
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25245789 · Cited by 2,789
Alzheimer’s disease: Targeting the glutamatergic system
Conway, M. E. (2020) · Biogerontology · doi:10.1007/s10522-020-09860-4 · Cited by 180
New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease
Zhang, F., Zhong, R.-J., Cheng, C., Li, S., & Le, W.-D. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00565-5 · Cited by 105
Alzheimer’s disease as type 3 diabetes: understanding the link and implications
Kciuk, M., Kruczkowska, W., Gałęziewska, J., Wanke, K., Kałuzińska-Kołat, Ż., Aleksandrowicz, M., & Kontek, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211955 · Cited by 98
Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer’s Drugs
Nunes, D., Loureiro, J. A., & Pereira, M. C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112296 · Cited by 68
Metadata
- Authors
- Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y.
- Affiliations
- Tsinghua University (CN)
- Capital Medical University (CN)
- Corresponding author
- Wu, Yan
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-02-08
- Volume
- 13
- Pages
- 43-43
- ISSN
- 1662-453X (ISSN-L)
- PMC
- PMC6375899
- OpenAlex
- W2911747652
- Cited by
- 535
- References
- 339
- Citations by year
- 2026: 51 · 2025: 80 · 2024: 82 · 2023: 103 · 2022: 92 · 2021: 71 · 2020: 47 · 2019: 9
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Neuroscience (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- NMDA receptor, Alzheimer's disease, amyloid-beta oligomers, synaptic dysfunction, synaptic depression, memantine, NMDA receptor subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review